Skip to main content
. 2016 Sep 23;17(10):1614. doi: 10.3390/ijms17101614

Figure 2.

Figure 2

Human cancer cells exhibit differential sensitivity to the anti-proliferative activity of SsCEI 4. The effects of peptide on cell viability were assessed in cancer cell lines belonging to Group 1, exposed for 24 (A) and 48 h (B) to increasing concentrations of SsCEI 4. Data are normalized to the values obtained with the untreated cells and are expressed as means ± SD values of triplicate data from three independent experiments.